Team:Oxford/MedalFulfilment
From 2014.igem.org
(Difference between revisions)
Line 43: | Line 43: | ||
<li id="ts2">Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry.<div id="s2" style="background-color:#EBEBEB;border-radius:12px;width:90%;margin-top:5px;height:25px;padding-left:10px;padding-right:10px;padding-top:5px;display:none;"><font style="font-weight:500;font-size:13px;">See our parts <a href="https://2014.igem.org/Team:Oxford/Parts" target="_blank">here!</a></font></div> </li> | <li id="ts2">Document the characterization of this part in the “Main Page” section of that Part’s/Device’s Registry entry.<div id="s2" style="background-color:#EBEBEB;border-radius:12px;width:90%;margin-top:5px;height:25px;padding-left:10px;padding-right:10px;padding-top:5px;display:none;"><font style="font-weight:500;font-size:13px;">See our parts <a href="https://2014.igem.org/Team:Oxford/Parts" target="_blank">here!</a></font></div> </li> | ||
<li id="ts3">Submit this new part to the iGEM Parts Registry (submissions must adhere to the iGEM Registry guidelines). <div id="s3" style="background-color:#EBEBEB;border-radius:12px;width:90%;margin-top:5px;height:25px;padding-left:10px;padding-right:10px;padding-top:5px;display:none;"><font style="font-weight:500;font-size:13px;">See our parts <a href="https://2014.igem.org/Team:Oxford/Parts" target="_blank">here!</a></font></div> </li> | <li id="ts3">Submit this new part to the iGEM Parts Registry (submissions must adhere to the iGEM Registry guidelines). <div id="s3" style="background-color:#EBEBEB;border-radius:12px;width:90%;margin-top:5px;height:25px;padding-left:10px;padding-right:10px;padding-top:5px;display:none;"><font style="font-weight:500;font-size:13px;">See our parts <a href="https://2014.igem.org/Team:Oxford/Parts" target="_blank">here!</a></font></div> </li> | ||
- | <li id="ts4">iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Articulate at least one question encountered by your team, and describe how your team considered the(se) question(s) within your project. Include attributions to all experts and stakeholders consulted. <div id="s4" style="background-color:#EBEBEB;border-radius:15px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:3%;padding-bottom:3%;width:90%;display:none;"><font style="font-weight:500;font-size:13px;"> | + | <li id="ts4">iGEM projects involve important questions beyond the bench, for example relating to (but not limited to) ethics, sustainability, social justice, safety, security, or intellectual property rights. Articulate at least one question encountered by your team, and describe how your team considered the(se) question(s) within your project. Include attributions to all experts and stakeholders consulted. <div id="s4" style="background-color:#EBEBEB;border-radius:15px; margin-top:2%; padding-left:2%;padding-right:2%;padding-top:3%;padding-bottom:3%;width:90%;display:none;"><font style="font-weight:500;font-size:13px;">The primary question researched by our team was very broad; How can an iGEM project change the real world? This allowed us to explore a huge range of different areas, from safety to intellectual property right to public opinion, all of which contribute to the success of a synthetic biology project outside of the lab. Our team considered these by consulting with parties affected by these issues, including the Environment Agency, iGEM start-up companies, and members of the public (including full attributions to all experts and stake-holders who assisted us) to gain an insight into the problems which might hold back syn bio solutions from implementation in society. We used this information together with our own experiences to think about how these potential road blocks can be successfully navigated, by the syn bio community and by society as a whole. </li> |
</ul> | </ul> | ||
<br><br> | <br><br> |
Revision as of 22:22, 17 October 2014